Artio Medical: Funding, Investors & Team (Sep 2026)
Artio Medical develops endovascular medical devices for the embolization of vessels, aneurysms, and other vascular structures. The company's first products enable precise and immediate occlusion and rapid sealing of cerebral aneurysms and other target vessel segments using an over-the-wire microcatheter platform. These products enable physicians to perform better, faster, and safer vascular occlusion procedures. The company was founded in 2011 and is based in Olathe, Kansas.
Artio Medical has raised $39.4M across 2 funding rounds on record, the most recent a Series A of $28.0M announced in Jun 2022.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Artio Medical Company Profile and Key Stats
Latest funding round on record: Jun 2022.
Artio Medical Funding Rounds
Artio Medical raised $11.4M in an undisclosed round announced in Feb 2022.
4 months later, a Series A of $28.0M was announced in Jun 2022.
Artio Medical Founders and Leadership Team
Contact details for the Artio Medical team: 1 of 1 has an email address on file.
Start 14-day free trial →Artio Medical Funding Compared to Other Biotechnology Startups
Artio Medical's latest round of $28.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Artio Medical in Biotechnology and Olathe
Companies Similar to Artio Medical
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Artio Medical Funding FAQs
What does Artio Medical do?
Artio Medical develops endovascular medical devices for the embolization of vessels, aneurysms, and other vascular structures. The company's first products enable precise and immediate occlusion and rapid sealing of cerebral aneurysms and other target vessel segments using an over-the-wire microcatheter platform. These products enable physicians to perform better, faster, and safer vascular occlusion procedures. The company was founded in 2011 and is based in Olathe, Kansas.
How much funding has Artio Medical raised?
Artio Medical has raised $39.4M across 2 rounds on record. The most recent is a Series A of $28.0M announced in Jun 2022.
When did Artio Medical last raise funding?
Artio Medical's most recent funding round on record is a Series A of $28.0M, announced in Jun 2022.
Who is the CEO of Artio Medical?
Nicholas Franano is listed as CEO at Artio Medical.
Where is Artio Medical headquartered?
Artio Medical is based in Olathe, Kansas, United States.
How many employees does Artio Medical have?
Artio Medical is in the 11-50 employee band.
How does Artio Medical's funding compare to other Biotechnology startups?
Artio Medical's latest round of $28.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's Artio Medical Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Artio Medical is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.